• Buprenorphine Linked to Lower Overdose Risk After Hospitalization

• Tackling the Root Causes of SUD: A Source Control Framework

• Higher Initial Buprenorphine Doses Linked to Lower Mortality

• Addressing the MOUD Knowledge Gap in Primary Care

• Prescription Opioids and OUD Risk

Read Here

• Increased Likelihood of Precipitated Withdrawal in Patients With Higher BMI’s and/or Elevated Urine Fentanyl Concentrations, When Transitioning From Illicit Fentanyl to Buprenorphine

• Understanding How to Appropriately Utilize Toxicology Testing in Addiction Medicine

• Greater Retention in Treatment Seen With Telemedicine Prescribing of Buprenorphine for Rural Patients

• SGLT2 Inhibitors Causing False Positive Toxicology Tests For Ethanol

• Healthcare Professionals Struggle With Use Disorders in Their Personal Lives as Well- A PCP’s Story About Her Son’s Addiction

Read Here

• Alcohol-Related ED Visits Linked to Increased Mortality Risk in Young Adults

• Understanding the Link Between Alcohol and Pain Relief

• GIP/GLP-1 RAs Linked to Reduced Overdose and Intoxication in OUD/AUD Patients

• The Interplay Between Opioid Misuse, Alcohol Misuse, and Distress in Patients with Chronic Pain

• Management of Alcohol Withdrawal in the Outpatient Setting: A Review of Treatment Options

Read Here

• The Role of Prescription Psychostimulants in Treating Amphetamine Use Disorder

• Rising Overdose Deaths: The Impact of Fentanyl and Psychostimulant Use

• COVID-19 & Stimulant Use in Youth: Unexpected Trends

• Naltrexone & Bupropion Combo Shows Promise for Methamphetamine Addiction

• Addressing Placebo Response Bias in Psychedelic Research: Comparing Psychedelics and Escitalopram for Depression

Read Here

• Integrating Buprenorphine into Community Healthcare: A Key Strategy for Combating the Opioid Crisis

• Trends in Opioid Overdose Deaths

• Challenging the Myths of Suboxone Diversion

• Expanding MOUD Access in Rural Areas: The Role of Telehealth and Hybrid Care Models

• Provider Hesitancy in Prescribing Buprenorphine

Read Here

• Pain Management for Pregnant Patients with Opioid Use Disorder: A Consensus Statement

• Comparing Buprenorphine-Naloxone and Buprenorphine for Opioid Use Disorder in Pregnancy

• Drug Overdose Risks Among Healthcare Workers in the U.S.

• The Adolescent Overdose Crisis

• Drug Poisoning and Other Factors Drive Increased Mortality in Young Adults

Read Here

• A New Standard for Opioid Equivalence: The NIH HEAL Initiative MME Calculator

• Evidence-Informed Strategies for Benzodiazepine Tapering: A Multi-Society Guideline

• Outpatient Buprenorphine Prescribing for Chronic Pain: A Retrospective Analysis of Trends

• Hospital Room Searches and Patient-Directed Discharge: A Retrospective Cohort Study

• Discharge MAUD Initiation Reduces Mortality and Hospital Readmission: A Medicare Part D Study

Read Here

• Medicaid Unwinding: Impact on Buprenorphine Access for OUD Patients

• Cannabis Use in Older Veterans: Insights for Clinicians

• Oral vs. Injectable Naltrexone for Hospitalized AUD Patients

• Heavy Cannabis Use and Working Memory in Young Adults

• Law Enforcement Seizures Linked to Increased Overdose Risk

Read Here

• Higher Buprenorphine Initiation Doses May Improve Treatment Retention for OUD in the Fentanyl Era

• Managing Acute Pain with Buprenorphine: Continuity is Key

• Opioid Prescribing: Understanding Patient and Prescription Risks for Misuse

• Unmasking the Power of Stigma: How Public Perceptions Hinder Addiction Recovery

• Overcoming Barriers to MOUD: Lessons from Patient Engagement

Read Here

• Cannabis Commercialization: Effects on Tobacco and Vaping Trends

• Soaring ED Visits for Cannabis Hyperemesis Syndrome Among Adolescents

• Telemedicine-Facilitated Hepatitis C Treatment Improves Cure Rates for Patients With OUD 

• Rescue Strategies for Smoking Cessation Treatment Failure

• Impact of Integrated Mental Health and Substance Use Services in Primary Care on Treatment Access

Read Here